Correction to “Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer” Wang, J, Wang, S, Wang, J, Huang, J, Lu, H, Pan, B, Pan, H, Song, Y, Deng, Q, Jin, X, Shi, G. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer. Cancer Med. 2023; 12(24): 22381–22394. doi: 10.1002/cam4.6734
{"title":"Correction to “Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer” Wang, J, Wang, S, Wang, J, Huang, J, Lu, H, Pan, B, Pan, H, Song, Y, Deng, Q, Jin, X, Shi, G. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer. Cancer Med. 2023; 12(24): 22381–22394. doi: 10.1002/cam4.6734","authors":"","doi":"10.1002/cam4.70214","DOIUrl":null,"url":null,"abstract":"<p>In section 2.7 on page 22383, “Tubulin (1:20000, Proteintech)” should have read “Actin (1:80000, ABclonal).” In Figure 3, Part A, on page 22388, “Tubulin” was incorrect and should have read “Actin.” Please see the corrected figure below. Although we used both Actin and Tubulin as the internal reference genes in the pre-experiment, the statistics of the data show Actin instead of Tubulin.</p><p>We apologize for these errors.</p>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.70214","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.70214","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
In section 2.7 on page 22383, “Tubulin (1:20000, Proteintech)” should have read “Actin (1:80000, ABclonal).” In Figure 3, Part A, on page 22388, “Tubulin” was incorrect and should have read “Actin.” Please see the corrected figure below. Although we used both Actin and Tubulin as the internal reference genes in the pre-experiment, the statistics of the data show Actin instead of Tubulin.
宫颈癌CNIH4临床预后及生物学意义的综合分析》Wang J, Wang S, Wang J, Huang J, Lu H, Pan B, Pan H, Song Y, Deng Q, Jin X, Shi G. 《宫颈癌CNIH4临床预后及生物学意义的综合分析》Correction to "Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer"（《宫颈癌CNIH4临床预后及生物学意义的综合分析》）.Cancer Med.Doi: 10.1002/cam4.6734.
期刊介绍：
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:
Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations
Cancer Biology:
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery.
Cancer Prevention:
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach.
Bioinformatics:
Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers.
Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
